Diagnosticos da America stock

DASA3 · B3 · BRL

Compare Diagnosticos da America
R$3.26Change from previous close: −6.86%Absolute change: −R$0.24

Close · November 19, 2026

Price history

+16.01% over the period

1 year: from R$2.81 (November 19, 2025) to R$3.26 (November 19, 2026), +16.01%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 19, 2026R$3.26
October 30, 2026R$2.98
September 30, 2026R$4.02
August 31, 2026R$2.61
July 31, 2026R$2.61
June 30, 2026R$2.71
May 29, 2026R$3.10
April 30, 2026R$3.38
March 31, 2026R$2.92
February 27, 2026R$4.03
January 30, 2026R$4.26
December 30, 2025R$4.54
November 28, 2025R$3.14
November 19, 2025R$2.81

At a glance

  • The company

    Provides diagnostic and hospital services, including medical consultancy and franchise contracting, in Brazil and Argentina

  • Latest results

    Quarter to September 30, 2026 · EPS R$0.05 (estimate R$0.01)

TickerLandia's take on Diagnosticos da America

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowR$2.00
52-wk highR$5.79

−43.70% from the 52-week high

Analysts · 12 analysts

Average targetR$4.05+24.23% vs. price

Buy 4 · Hold 8 · Sell 0

TickerLandia Fingerprint: Diagnosticos da America

Compared with similar companies: very low price, very high risk, and very low profitability.

Financials and price compared with 27 companies in the diagnostics & research industry, worldwide. Momentum and risk compared with 317 Latin American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Diagnosticos da America is cheaper than similar companies

Diagnosticos da America's Forward P/E: 12.8, −28% against the median of a group of 11 similar companies (17.9).

Compared with 11 similar companies

Diagnosticos da America's metrics compared with similar companies
MetricDiagnosticos da AmericaPosition in the groupBand
Forward P/E12.8Low
Operating margin10.9%Low
ROE-10.7%Low
Debt/equity1.10High
Price/book0.58Low

Grey band: the middle half of the group; tick: the median; dot: Diagnosticos da America. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

R$2.41B

Latest quarter · Q3 2026

Net income

R$173.34M

Latest quarter · Q3 2026

Quarterly net margin

7.2%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
R$4.07B
EPS
-R$0.65
Volume
1.38M
Daily trading
€1.23M

How Diagnosticos da America is changing

All results
  • Revenue grew 9.7% a year on average over the last 5 years

  • Operating margin rose from 7.7% to 9.0%

  • Shares outstanding up 161.1% in 5 years

Returns

Diagnosticos da America returns with dividends

R$1,000 invested in Diagnosticos da America 5 years ago, on November 19, 2021, would be worth R$88 today with dividends reinvested: −91.20% in total, −38.51% per year. On price alone it would be R$87 (−91.28%).

PeriodDiagnosticos da AmericaIbovespaR$1,000 becomes
1 month−38.49%−18.87%R$615
6 months+8.67%−4.53%R$1,087
Year to date−28.19%+3.26%R$718
1 year+16.01%+7.08%R$1,160
3 years−68.32%+31.94%R$317
5 years−91.20%+61.48%R$88
10 years−81.53%+172.43%R$185

Over the last 6 months it has done better than 43% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. Ibovespa: with dividends. Calculate your investment

The chart in detail

Diagnosticos da America: technical analysis

Diagnosticos da America shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 98.4% below its all-time closing high (R$199.00, January 19, 2021).

Trend
No clear trend
RSI (14 sessions)
44
Between 30 and 70
vs 200-session average
−0.57%

Support and resistance

Price areas where Diagnosticos da America has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. ResistanceR$3.88+18.87%2 touches, last on March 25, 2026
  2. ResistanceR$3.61+10.82%7 touches, last on November 11, 2026
  3. ResistanceR$3.27+0.31%2 touches, last on July 24, 2026
  4. Last priceR$3.26
  5. SupportR$2.90−11.04%8 touches, last on September 8, 2026
  6. SupportR$2.48−24.01%7 touches, last on November 3, 2026

Volatility and risk

Over the last year it has moved more than the Ibovespa.

Beta (1 year) vs Ibovespa
2.54
Volatility (60 sessions, annualised)
152.7%
Largest fall in the last year
−55.85%

Close of November 19, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Diagnosticos da America: seasonality

Average monthly price change over 22 years

+6.9%Jan−0.7%Feb−4.7%Mar−0.3%Apr−1.2%May−2.1%Jun+2.4%Jul+1.8%Aug−0.3%Sep−2.4%Oct+5.6%Nov+6.2%Dec

Over the last 22 years, the strongest month for Diagnosticos da America has been January: +6.86% on average, positive in 13 years out of 22. The weakest has been March: −4.72% on average, positive in 10 years out of 22. November, the current month, has been positive in 9 years out of 21 (+5.63% on average).

Show chart data
MonthAverageMedianPositive years
January+6.86%+2.38%13 of 22
February−0.68%−1.18%10 of 22
March−4.72%−2.83%10 of 22
April−0.31%−1.45%10 of 22
May−1.23%+0.39%12 of 22
June−2.10%−3.22%9 of 22
July+2.44%+1.21%12 of 22
August+1.79%−0.70%10 of 22
September−0.27%−3.00%7 of 22
October−2.44%−1.51%8 of 22
November+5.63%−0.51%9 of 21
December+6.24%+5.14%15 of 22

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Diagnosticos da America and its competitors

Clinical diagnostics, hospital care and oncology services in Brazil and Argentina form the core of Diagnósticos da América S.A., which was founded in 1961 and was formerly known as Laboratório Clínico Delboni Auriemo S.A. until it changed its name in August 2000. The company reports through three segments: hospitals and oncology, national diagnostics operations in Brazil, and international diagnostics operations. Its offering also includes medical services, property and vehicle rental, consultancy and franchise contracting.

Headquarters
São Paulo, Brazil
Employees
26,255
Founded
1961
Chief executive
Rafael Lucchesi
Diagnosticos da America and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Diagnosticos da AmericaDASA3$686.17M10.9%—+8.67%
FleuryFLRY3$1.97B16.0%15.0+37.09%
DiagnostykaDIA$1.27B14.9%20.2−6.62%
DiaSorinDIA$4.21B22.3%28.6+14.88%
Sonic HealthcareSHL$7.13B9.3%17.6+17.41%
WuXi XDC Cayman2268$9.64B28.1%46.6+3.47%

Same industry or related industries, similar size. Compare Diagnosticos da America with its competitors · Full profile